3 Methylglutaconic Aciduria Type Viib C5676893 vs 3p25 3 Microdeletion Syndrome C5437630

Choose 3 Methylglutaconic Aciduria Type Viib C5676893 when

• Early neurological or developmental concern with a suspected metabolic cause

  The source places onset at ages 0–5 and classifies it as severe and metabolic.

  Moderate

• Mitochondrial disorder is being considered

  The description specifically links the condition to mitochondrial dysfunction.

  High

• Organic-acid testing suggests 3-methylglutaconic aciduria

  That pattern would favor specialist evaluation for this metabolic diagnosis over a chromosomal label.

  Moderate

Choose 3p25 3 Microdeletion Syndrome C5437630 when

• A chromosomal microarray finds missing material at 3p25.3

  The diagnosis is defined by that chromosomal change rather than a metabolic result.

  High

• Developmental delay occurs with distinctive features or possible organ anomalies

  These are the features supplied for the microdeletion syndrome.

  Moderate

• No metabolic abnormality is identified but a congenital genetic syndrome remains suspected

  The source classifies it as congenital and genetic, with onset not precisely established.

  Moderate

3 Methylglutaconic Aciduria Type Viib C5676893

Outcome

Long-term outcome is not established; the source labels it severe and lifelong.

Factors

Neurological and developmental problems and individual response to supportive care.

3p25 3 Microdeletion Syndrome C5437630

Outcome

Outcome is not established; the source labels severity moderate and course chronic.

Factors

Extent of developmental delay and any heart or organ involvement.